摘要
随着外科技术、免疫抑制方案以及术后处理等关键技术的进步,小肠移植患者的1年和5年存活率分别达到70%和50%。一直以来,小肠移植术后的死亡原因变化不大,感染仍然是最主要原因,高达51%,其次为排斥反应(8%)、淋巴瘤(3%)、技术失败(3%)。
出处
《器官移植》
CAS
2011年第3期175-180,共6页
Organ Transplantation
基金
国家科技支撑计划项目(2008BAI60B06)
参考文献56
-
1Grant D.Intestinal transplant registry[C/OL] //Ⅺ International Small Bowel Transplant Symposium.Bologna,Italy,Sept 9-12,2009[2009-10-01].http://tts2.org/multimedia/ITA/ISBTS2009_Bologna/Registry_ITA.html.
-
2Middleton SJ,Jamieson NV.The current status of small bowel transplantation in the UK and internationally[J].Gut,2005,54(11):1650-1657.
-
3Cicalese L,Sileri P,Asolati M,et al.Infectious complications following living-related small bowel transplantation in adults[J].Transplant Proc,2001,33(1-2):1554-1555.
-
4Abu-Elmagd K,Todo S,Tzakis A,et al.Three years clinical experience with intestinal transplantation[J].J Am Coll Surg,1994,179(4):385-400.
-
5Kusne S,Furukawa H,Abu-Elmagd K,et al.Infectious complications after small bowel transplantation in adults:an update[J].Transplant Proc,1996,28(5):2761-2762.
-
6Peleg AY,Husain S,Kwak EJ,et al.Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab,a humanized monoclonal CD-52 antibody[J].Clin Infect Dis,2007,44(2):204-212.
-
7Tzakis AG,Kato T,Levi DM,et al.100 multivisceral transplants at a single center[J].Ann Surg,2005,242(4):480-490.
-
8Abu-Elmagd KM,Costa G,Bond GJ,et al.Five hundred intestinal and multivisceral transplantations at a single center:major advances with new challenges[J].Ann Surg,2009,250(4):567-581.
-
9Foster PF,Sankary HN,McChesney L,et al.Cytomegalovirus infection in the composite liver/intestinal/pancreas allograft[J].Transplant Proc,1996,28(5):2742-2743.
-
10Fryer JP.Intestinal transplantation:current status[J].Gastroenterol Clin North Am,2007,36(1):145-159.
二级参考文献62
-
1李宁,黎介寿,李幼生,江志伟,尹路,张利华,任建安,舒志军.我国首例异体小肠移植成功的临床经验[J].解放军医学杂志,1994,19(4):252-254. 被引量:16
-
2侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:863
-
3Bond GJ, Mazariegos GV, Sindhi B, et al. Evolutionary experience with immunosuppression in pediatric intestinal transplantation. J Pediatr Surg, 2005, 40:274-279.
-
4Selvaggi G, Gaynor JJ, Moon J, et al. Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience. Am J Transplant, 2007,7 : 1249-1257.
-
5Fishbein TM, Matsumoto CS. Regimens for intestinal transplant immunosuppression. Curr Opin Organ Transplant,2005, 10:120- 123.
-
6Tzakis AG, Kato T, Nishida S, et al. Alemtuzumab ( Campath- 1H) combined with tacrolimus in intestinal and multivisceral transplantation. Transplantation,2003,75, 1512-1517.
-
7Cicalese L, Sileri P, Green M, et al. Bacterial translocation in clinical intestinal transplantation. Transplantation,2001,71 : 1414- 1417.
-
8Beath SV. Closure and summary of Ninth International Small Bowel Transplantation Symposium. Transplant Proc, 2006, 38 : 1657-1658.
-
9The US: Organ procurement and transplantation network and the scientific registry of transplant recipients. The 2007 OPTN/SRTR annual report : transplant data 1997 - 2006 [ M/OL ]. http :// www. optn, org. 2008,6.
-
10Watson CJE, Bradley JA, Friend PJ, et al. Alemtuzumab ( CAMPATH 1H) induction therapy in cadaveric kidney transplantation-efficacy and safety at five years[ J]. Am J Transplant,2005, 5(6) :1347 - 1533.
共引文献27
-
1李元新,黎介寿.人源化CD52单克隆抗体在器官移植中的应用[J].中国实用外科杂志,2008,28(11):984-987. 被引量:6
-
2李元新,李宁,倪小冬,李幼生,李民,沈璟,黎介寿.小肠移植围手术期的营养支持[J].肠外与肠内营养,2008,15(6):335-338. 被引量:8
-
3李元新,李宁,倪小冬,李幼生,李民,沈璟,黎介寿.小肠移植中应用Campath 1H诱导和低剂量他克莫司维持抗排斥治疗[J].中华外科杂志,2009,47(11):810-813. 被引量:9
-
4李元新,李宁,李幼生,倪小冬,李民,吴波,王剑,黎介寿.部分免疫耐受诱导方案在小肠移植中的应用[J].中华医学杂志,2009,89(38):2695-2698. 被引量:5
-
5李元新,李宁,李幼生,倪小冬,李民,汪志明,吴波,王剑,黎介寿.小肠移植术后排斥反应的诊断与治疗四例报告[J].中华器官移植杂志,2009,30(12):733-736. 被引量:6
-
6李元新,李宁,李幼生,倪小冬,王剑,黎介寿.小肠移植后并发侵袭性真菌感染的治疗[J].中华器官移植杂志,2010,31(2):97-100. 被引量:10
-
7李元新,李宁.小肠移植:一个时代的到来[J].器官移植,2010,1(2):69-72. 被引量:15
-
8杨秀芳,彭南海,徐丹丹,叶向红,李幼生,李宁.5例同种异体小肠移植术后移植肠造口的护理[J].中华护理杂志,2010,45(4):296-298. 被引量:7
-
9李元新,李宁,李幼生,汪志明,吴波,倪小冬,王剑,黎介寿.小肠移植术后内镜引导下移植肠黏膜活检的时机及诊断价值[J].中华器官移植杂志,2010,31(10):584-588. 被引量:8
-
10王凯,李元新,李宁,李幼生,倪小冬,王剑,赵振国,郭明晓,黎介寿.小肠移植术后免疫抑制治疗的随访与监测[J].中华器官移植杂志,2011,32(5):281-285. 被引量:1
同被引文献68
-
1<应用抗菌药物防治外科感染的指导意见>撰写协作组.应用抗菌药物防治外科感染的指导意见(草案)ⅩⅤ——小肠移植术后感染的防治[J].中华外科杂志,2004,42(22):1389-1390. 被引量:4
-
2郭华,梁廷波,王伟林,沈岩,张珉,郑树森.成人肝移植后淋巴组织增生性疾病二例[J].中华外科杂志,2006,44(21):1467-1468. 被引量:5
-
3李卉,张淑英,王政禄,朱丛中,蔡文娟,郑虹,沈中阳.肝移植术后淋巴组织增生性疾病的临床病理分析[J].临床与实验病理学杂志,2007,23(4):404-407. 被引量:3
-
4Nalesnik MA.Clinicopathologic characteristics of post-transplant lymphoproliferative disorders[J].Recent Results Cancer Res,2002,159:9-18.
-
5Greiner T,Armitage JO,Gross TG.Atypical lymphoproliferative diseases[J].Hematology Am Soc Hematol Educ Program,2000:133-146.
-
6Darenkov IA,Marcarelli MA,Basadonna GP,et al.Reduced incidence of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder using preemptive antiviral therapy[J].Transplantation,1997,64(6):848-852.
-
7Swinnen LJ.Diagnosis and treatment of transplant-related lymphoma[J].Ann Oncol,2000,11(Suppl 1):45-48.
-
8Faller DV,Mentzer SJ,Perrine SP.Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies[J].Curr Opin Oncol,2001,13(5):360-367.
-
9Cantarovich M,Barkun JS,Forbes RD,et al.Successful treatment of post-transplant lymphoproliferative disorder with interferon-alpha and intravenous immunoglobulin[J].Clin Transplant,1998,12(2):109-115.
-
10Jagadeesh D,Woda BA,Draper J,et al.Post transplant lymphoproliferative disorders:risk,classification,and therapeutic recommendations[J].Curr Treat Options Oncol,2012,13(1):122-136.
引证文献3
-
1汪根树,汪国营,李华,张剑,姜楠,傅斌生,金海,杨建旭,李势辉,杨扬,陈规划.肝移植术后淋巴组织增生性疾病的诊断和治疗(附1例报告及文献复习)[J].器官移植,2012,3(4):185-189. 被引量:1
-
2李元新.小肠移植的关键外科技术[J].器官移植,2012,3(3):121-126. 被引量:4
-
3丁维燕,卢芳燕,董丽.1例胰腺癌新辅助治疗后行胰十二指肠切除联合自体小肠移植患者的护理[J].加速康复外科杂志,2020,3(4):179-182.
二级引证文献5
-
1谢占涛,孙建军,赵会博,汤高枫,魏思东,陈永峰,徐化恩,李彩丽,陈国勇.肝移植过程中合并小肠坏死2例[J].中国组织工程研究,2013,17(44):7715-7720.
-
2中培培,吕雪青,叶伟,李娟.小肠移植手术护理配合关键点探讨[J].浙江临床医学,2015,17(9):1649-1650.
-
3李元新.小肠移植发展现状、困惑与挑战[J].器官移植,2016,7(1):8-13. 被引量:9
-
4郝新民,王明亮,曾蒙苏.肝脏假淋巴瘤的MRI表现[J].放射学实践,2019,34(10):1128-1131. 被引量:1
-
5卢露,卢芳燕,戴燕红,姚彩萍,陶玉侠,张婉莹.异体小肠移植联合腹壁移植患者的术后护理[J].中华急危重症护理杂志,2022,3(2):190-192. 被引量:1
-
1梁平,赵平.胰肾联合移植并发症的处理[J].激光杂志,2001,22(4):63-65.
-
2王晓航.肺移植术的术后管理[J].山东医药,2008,48(36):110-111.
-
3杨昕,朱天岳,文立成.肾移植术后人工髋关节置换的治疗特点[J].中国矫形外科杂志,2011,19(8):655-657. 被引量:2
-
4周霖,杨永平.肝细胞体内移植并发症及处理[J].肝脏,2006,11(3):218-218.
-
5李世德.肿瘤性假体置换61例报告[J].西藏医药,1999,20(S1):96-96.
-
6周燕,唐燕,毛维.彩色多普勒超声诊断肾移植并发症的价值探讨[J].齐齐哈尔医学院学报,2008,29(16):1993-1993. 被引量:1
-
7林栋栋,卢实春,李宁.活体肝移植后胆道并发症的预防和处理策略[J].中华器官移植杂志,2010,31(12):769-771. 被引量:2
-
8张海波,夏求明,张国伟.一氧化氮在心脏和血管移植免疫反应中的作用[J].心血管康复医学杂志,2002,11(2):189-191.
-
9线粒体多态性或影响心脏移植预后[J].中国医药科学,2011,1(16):8-8.
-
10郑树森,吴健.应重视肝移植并发症的预防[J].中华医学杂志,2005,85(24):1657-1659. 被引量:14